Related Experiment Video
Updated: May 5, 2026
07:26
Isolation of Functional Cardiac Immune Cells
Published on: December 5, 2011
14.6K
Pathophysiological role of cytokines in congestive heart failure
Annual Review of Medicine
|February 13, 2001
Insights
Heart failure involves inflammation and specific cytokines. Targeting these inflammatory cytokines with monoclonal antibodies may help reverse cardiac depression and halt heart failure progression.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Heart failure is a complex syndrome involving neurohumoral and inflammatory pathways.
- Proinflammatory cytokines, including interleukin-1, interleukin-2, interleukin-6, interleukin-10, and tumor necrosis factor, are implicated in cardiac dysfunction.
- These cytokines play a role in the progression of heart failure.
Purpose of the Study:
- To elucidate the role of specific proinflammatory cytokines in the pathogenesis of heart failure.
- To explore the potential of targeting these cytokines as a therapeutic strategy for heart failure.
Main Methods:
- Review of recent studies on cytokine involvement in heart failure.
- Analysis of the mechanisms by which cytokines contribute to cardiac depression.
- Consideration of therapeutic approaches using monoclonal antibodies.
Main Results:
- Proinflammatory cytokines are key mediators in the development and progression of heart failure.
- Cytokine-induced cardiac depression is a significant component of the heart failure syndrome.
- Monoclonal antibodies offer a potential method to neutralize specific cytokines.
Conclusions:
- Understanding the role of proinflammatory cytokines is crucial for developing novel heart failure treatments.
- Targeting specific cytokines with monoclonal antibodies may offer a way to reverse cardiac depression.
- This approach holds promise for blocking the progression of heart failure.
Abstract:
Heart failure is a complex neurohumoral and inflammatory syndrome. Recent studies have shown that proinflammatory cytokines (interleukin-1, interleukin-2, interleukin-6, interleukin-10, and tumor necrosis factor) are involved in cardiac depression and in the complex syndrome of heart failure. Understanding the involvement of these cytokines may enable us to reverse cardiac depression and heart failure by the use of monoclonal antibodies directed against specific cytokines to block the downhill progression of heart failure.
Related Concept Videos
01:17Pathophysiology of Heart Failure
4.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
01:22Heart Failure Drugs: Diuretics
1.6K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
01:26Imbalances in Cardiac Output
3.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
01:27Heart Failure I: Introduction
1.7K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.7K
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
01:22Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632